Oxybutynin Oral Tablet, Extended Release 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Oxybutynin: Oral tablet, extended release (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_8619.JPG
Oxybutynin 10mg ER Tab
Mylan Pharmaceuticals Inc.
Pill Identification: M O 10 
Drug Image file DrugItem_13643.JPG
Oxybutynin 10mg ER Tab
Teva Pharmaceuticals USA
Pill Identification: G 342 
Drug Image file DrugItem_25093.JPG
Oxybutynin 10mg ER Tab
Accord Healthcare, Inc.
Pill Identification: EM2 
Drug Image file DrugItem_14634.JPG
Oxybutynin 10mg ER Tab
Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company. Inc.
Pill Identification: KU  |  271
Drug Image file DrugItem_20740.JPG
Oxybutynin 10mg ER Tab
Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of McNEIL-PPC, Inc
Pill Identification: 10 XL 

What is this Medicine?

OXYBUTYNIN (ox i BYOO ti nin) is used to treat overactive bladder. This medicine reduces the amount of bathroom visits. It may also help to control wetting accidents.

CVS Pharmacy Patient Statistics for Oxybutynin: Oral tablet, extended release(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Oxybutynin Chloride 10mg Extended-Release Tablet

NDC: 003786610
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Storage Information
Avoid excessive humidity
Protect from moisture
Store at controlled room temperature (between 68 and 77 degrees F)
Oxybutynin Chloride 10mg Extended-Release Tablet
Drug Image file DrugItem_8619.JPG
Mylan Pharmaceuticals Inc.
Pill Identification: M O 10 
Shape: round
Color: peach
Daily Life Interactions for Oxybutynin Chloride 10mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Oxybutynin Chloride 10mg Extended-Release Tablet(Oxybutynin Chloride)
Grapefruit juice and Oxybutynin(Oxybutynin Chloride)
Grapefruit juice and grapefruit-containing foods may increase the side effects of oxybutynin. Do not significantly increase grapefruit juice intake while taking this drug, or avoid grapefruit juice if possible. Discuss any new or worsening side effects, such as confusion, constipation, dizziness, difficulty with urination, drowsiness, dry mouth and eyes, changes in vision, palpitations, or fast heartbeat with your health care provider. Do not drive or operate machinery until you know how these drugs affect you.
Moderate Lifestyle Interaction
Alcohol and Oxybutynin Chloride 10mg Extended-Release Tablet(Oxybutynin Chloride)
Alcohol and Oxybutynin(Oxybutynin Chloride)
Do not drink Alcoholic beverages while taking Oxybutynin. You may feel drowsy or more tired if you drink alcohol-containing drinks while taking this drug. Do not drive or operate machinery while drinking alcoholic beverages and until you know how oxybutynin affects you. You may also notice an increase in the frequency of urination while taking Oxybutynin and drinking alcoholic beverages.
Minor Lifestyle Interaction
Caffeine-containing Foods/Beverages and Oxybutynin Chloride 10mg Extended-Release Tablet(Oxybutynin Chloride)
Caffeine-containing Foods/Beverages and Oxybutynin(Oxybutynin Chloride)
The intake of beverages containing caffeine may decrease the actions of oxybutynin because caffeine may increase urination. You may wish to limit your caffeine intake (including intake of coffee, colas, teas, or herbal supplements) while taking oxybutynin.
Pregnancy & Lactation Information
First Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Second Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Third Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Oxybutynin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.